The American Hospital Association (AHA) last week told the U.S. Centers for Medicare & Medicaid Services (CMS) that insurance company UnitedHealthcare’s (UHC) specialty pharmacy coverage policies “undermine the intent of the 340B program” and should be disallowed.
In a Feb. 4 letter, AHA told CMS that UHC “is upending the traditional system” in which hospitals buy, store, and administer specialty drugs and then bill payers for the cost and administration of such drugs. It said UHC health plans “are no longer permitting many providers (under penalty of non-payment) to acquire and store a variety of drugs needed to treat their patients.”
The American Hospital Association (AHA) last week told the U.S. Centers for Medicare & Medicaid Services (CMS) that insurance company UnitedHealthcare’s (UHC)
specialty pharmacy coverage policies “undermine the intent of the 340B program” and should be disallowed.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
